asthma

News

Black and white image of a man putting his finger to his lips to shush

AZ, Organon fall foul of UK's code on pharma promotion

AstraZeneca and Organon have breached the UK pharma industry's code of practice with promotions for an asthma drug and a contraceptive implant.

News

Trials set up filings for AZ's triple therapy in asthma

AstraZeneca's three-drug inhaler Breztri has shown efficacy for uncontrolled asthma in a pair of trials that could extend its label beyond COPD.

News

Sanofi's 'daughter of Dupixent' heads to phase 3 in asthma

Sanofi is preparing a phase 3 programme for asthma candidate amlitelimab, despite mixed data in a phase 2 trial.

News

Stopwatch starts on reviews of GSK's long-acting asthma drug

Regulators have started reviews of GSK's depemokimab, aiming to become the first drug for asthma that can be dosed twice a year.

News

Study finds AZ's benralizumab a 'game-changer' in asthma

Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if it was used to treat acute asthma attacks

News

AZ, Avillion's Airsupra aces asthma rescue therapy trial

A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy.

AZ, Organon fall foul of UK's code on pharma promotion

Trials set up filings for AZ's triple therapy in asthma

Sanofi's 'daughter of Dupixent' heads to phase 3 in asthma

Stopwatch starts on reviews of GSK's long-acting asthma drug

Study finds AZ's benralizumab a 'game-changer' in asthma

AZ, Avillion's Airsupra aces asthma rescue therapy trial

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

asthma

Editor's Picks